ArticleBMJ open2025

Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension.

Maria L Bageta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.